anticancer


Also found in: Dictionary, Medical, Encyclopedia.
Related to anticancer: anticancer diet, Anticancer Drugs
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • adj

Synonyms for anticancer

used in the treatment of cancer

References in periodicals archive ?
With many studies suggesting that soybeans possess anticancer activity, a team of midwestern scientists recently began probing the gooey wastes left over from the commercial extraction of oil and protein from soy.
Paclitaxel is an important cytotoxic agent that will expand the Lederle and Immunex arsenal of anticancer drugs, while allowing us to participate in a growing market segment of cytotoxic drugs," stated Cyanamid Group Vice President David R.
He suggests that the anticancer drugs not only damage cancer cells directly but also sensitize them to radiation.
and abroad having confirmed ATP's potential anticancer activities.
Researchers conclude that such relapses occur because the cells that persist despite anticancer treatments had an enormous competitive advantage over the other malignant cells in the tumor.
Henry Brem, a neurosurgeon at the Johns Hopkins Medical Institutions in Baltimore, is developing small polymer disks containing anticancer drugs for implantation at tumor sites.
Our grant to the NFCR Center for Proteomics and Drug Actions brings together three of the top chemical scientists in proteomics research linking them in with other researchers around the world to work on the development of new anticancer drugs.
Most anticancer drugs attack a variety of cancers but harm some body cells as well.
Driscoll earned a PhD in chemistry from Princeton University and after eight years as Research Group Leader in private industry, he joined the National Cancer Institute (NCI), National Institutes of Health, in Bethesda, MD where he initiated an intramural research program for the discovery of new anticancer drugs.
Taxol - the complex anticancer compound derived from the bark of the Pacific yew tree, Taxus brevifolia- has finally yielded to the ingenuity of two chemistry research teams.
Nasdaq: IMGN) today announced the presentation of clinical data from a Phase I study evaluating the Company's huN901-DM1 anticancer agent for the treatment of small-cell lung cancer (SCLC) and other CD56-expressing solid tumors.
this one for liver cancer, has enabled researchers to increase the dose of anticancer drugs.